We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Can AEHR Turn Silicon Photonics Momentum Into Sustained Growth?
Read MoreHide Full Article
Key Takeaways
Its newest major customer has ordered two FOX test cells and two FOX-NP systems.
AEHR's lead silicon photonics customer is ramping production and placing follow-on wafer-level burn-in orders.
AEHR projects $130-$150 million in fiscal 2027 revenue, with non-GAAP net income at 18%-22%.
Aehr Test Systems, Inc. (AEHR - Free Report) is gaining momentum in silicon photonics, giving it another potential growth driver alongside AI processors. Demand for production burn-in is increasing as AI data centers rely more on optical I/O and high-speed interconnects. The company believes the silicon photonics and optical test and burn-in market could become a meaningful long-term growth driver.
Aehr’s lead silicon photonics customer is ramping up production and has placed follow-on orders for fully automated wafer-level burn-in systems. Its newest major customer, a global networking products provider, expects additional systems as it expands capacity to support next-generation hyperscale data center deployments. The customer first engaged with AEHR last November and has already ordered two FOX test cells and two FOX-NP systems.
The financial opportunity is becoming more visible. Management currently expects silicon photonics to account for roughly 15-20% of fiscal 2027 revenues, while total revenues are projected to be in the band of $130-$150 million. The outlook is largely based on current customers, and AEHR is not assuming any memory revenue in this guidance. Non-GAAP net income is also expected to reach 18-22% of total revenues in fiscal 2027.
Continued production ramp ups and additional system orders will be important to watch. The company’s growing presence across existing and new customers could help expand the contribution of this market to fiscal 2027 revenues. With silicon photonics already expected to account for 15-20% of fiscal 2027 revenues, further customer ramp ups could make it an increasingly important part of AEHR’s growth.
AEHR’s Key Competitors
Aehr operates in a highly competitive semiconductor test equipment market, competing with established players like FormFactor, Inc. (FORM - Free Report) and Teradyne, Inc. (TER - Free Report) .
FormFactor is seeing demand for its semiconductor test solutions from AI, advanced packaging and silicon photonics. FORM is positioned to benefit as chipmakers increase testing requirements for increasingly complex semiconductor devices.
Teradyne is benefiting from semiconductor testing demand linked to AI and advanced computing. TER also has a broad customer base across the semiconductor industry, giving it exposure to continued investments in data centers and next-generation computing.
AEHR’s shares have surged 59.3% over the past month, outperforming the broader industry’s 17.9% growth.
Image Source: Zacks Investment Research
Aehr’s shares are trading at a premium. In terms of the forward 12-month price-to-sales (P/S), AEHR is trading at 25.65X, higher than the industry’s 6.67X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for AEHR’s fiscal 2027 earnings is pinned at 70 cents per share, implying a sharp increase from 3 cents a year ago.
View the Zacks #1 Rank List
Image: Bigstock
Can AEHR Turn Silicon Photonics Momentum Into Sustained Growth?
Key Takeaways
Aehr Test Systems, Inc. (AEHR - Free Report) is gaining momentum in silicon photonics, giving it another potential growth driver alongside AI processors. Demand for production burn-in is increasing as AI data centers rely more on optical I/O and high-speed interconnects. The company believes the silicon photonics and optical test and burn-in market could become a meaningful long-term growth driver.
Aehr’s lead silicon photonics customer is ramping up production and has placed follow-on orders for fully automated wafer-level burn-in systems. Its newest major customer, a global networking products provider, expects additional systems as it expands capacity to support next-generation hyperscale data center deployments. The customer first engaged with AEHR last November and has already ordered two FOX test cells and two FOX-NP systems.
The financial opportunity is becoming more visible. Management currently expects silicon photonics to account for roughly 15-20% of fiscal 2027 revenues, while total revenues are projected to be in the band of $130-$150 million. The outlook is largely based on current customers, and AEHR is not assuming any memory revenue in this guidance. Non-GAAP net income is also expected to reach 18-22% of total revenues in fiscal 2027.
Continued production ramp ups and additional system orders will be important to watch. The company’s growing presence across existing and new customers could help expand the contribution of this market to fiscal 2027 revenues. With silicon photonics already expected to account for 15-20% of fiscal 2027 revenues, further customer ramp ups could make it an increasingly important part of AEHR’s growth.
AEHR’s Key Competitors
Aehr operates in a highly competitive semiconductor test equipment market, competing with established players like FormFactor, Inc. (FORM - Free Report) and Teradyne, Inc. (TER - Free Report) .
FormFactor is seeing demand for its semiconductor test solutions from AI, advanced packaging and silicon photonics. FORM is positioned to benefit as chipmakers increase testing requirements for increasingly complex semiconductor devices.
Teradyne is benefiting from semiconductor testing demand linked to AI and advanced computing. TER also has a broad customer base across the semiconductor industry, giving it exposure to continued investments in data centers and next-generation computing.
AEHR’s Share Price Performance, Valuation & Estimates
AEHR’s shares have surged 59.3% over the past month, outperforming the broader industry’s 17.9% growth.
Image Source: Zacks Investment Research
Aehr’s shares are trading at a premium. In terms of the forward 12-month price-to-sales (P/S), AEHR is trading at 25.65X, higher than the industry’s 6.67X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for AEHR’s fiscal 2027 earnings is pinned at 70 cents per share, implying a sharp increase from 3 cents a year ago.
Image Source: Zacks Investment Research